San Francisco, California
United States
53
2026-06-18
The entities that hold a legal rights for patent applications filed by inventor Lazerwith Scott E.:
Scott E. Lazerwith from San Francisco, US has applied for patents for these inventions. The list has both pending applications and granted patents:
KRAS MODULATING COMPOUNDS
#2 | 2026-04-30KRAS G12D MODULATING COMPOUNDS
#3 | 2026-04-09KRAS MODULATING COMPOUNDS
#4 | 2025-07-17AZASPIRO WRN INHIBITORS
#5 | 2025-05-15MCL-1 INHIBITORS
#6 | 2025-05-01KRAS G12D MODULATING COMPOUNDS
#7 | 2025-04-03KRAS G12D MODULATING COMPOUNDS
#8 | 2025-03-27KRAS G12D MODULATING COMPOUNDS
#9 | 2025-02-13THIENOPYRROLE COMPOUNDS
#10 | 2025-02-06KRAS MODULATING COMPOUNDS
#11 | 2025-02-06SARS-COV2 MAIN PROTEASE INHIBITORS
#12 | 2025-01-026-SUBSTITUTED INDOLE COMPOUNDS
#13 | 2024-11-21KRAS Modulating Compounds
#14 | 2024-07-18SARS-COV2 MAIN PROTEASE INHIBITORS
#15 | 2024-07-04THIENOPYRROLE COMPOUNDS
#16 | 2024-04-11SARS-COV2 main protease inhibitors
#17 | 2024-02-22SUBSTITUTED INDOLE COMPOUNDS
#18 | 2024-01-25PHOSPHOLIPID COMPOUNDS AND USES THEREOF
#19 | 2023-11-23KRAS G12D MODULATING COMPOUNDS
#20 | 2023-11-16THIENOPYRROLE COMPOUNDS
#21 | 2023-10-26KRAS G12D MODULATING COMPOUNDS
#22 | 2023-10-05Capsid inhibitors for the treatment of HIV
#23 | 2023-10-05MCL-1 inhibitors
#24 | 2023-08-10Phospholipid compounds and uses thereof
#25 | 2023-08-10Phospholipid compounds and uses thereof
#26 | 2017-05-11Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#27 | 2017-04-27POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#28 | 2017-03-02Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infections
#29 | 2017-02-02Antiviral compounds
#30 | 2016-12-22Syk inhibitors
#31 | 2016-10-06Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#32 | 2016-07-07POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#33 | 2016-06-23Substituted 1,2,3,4,6,8,12,12a-octahydro-1,4-methanodipyrido[1,2-a:1',2'-d]pyrazines and methods for treating viral infections
#34 | 2016-06-23Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#35 | 2016-04-21Therapeutic compounds
#36 | 2015-12-24SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS
#37 | 2015-02-05Substituted pyrrolidines as SYK inhibitors
#38 | 2015-01-15Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#39 | 2014-09-04Antiviral compounds
#40 | 2014-08-07Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections
#41 | 2014-08-07POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#42 | 2014-02-20Antiviral compounds
#43 | 2014-02-06Antiviral compounds
#44 | 2014-01-30INHIBITORS OF FLAVIVIRIDAE VIRUSES
#45 | 2013-12-05Inhibitors of viruses
#46 | 2013-11-28Inhibitors of viruses
#47 | 2013-05-30Antiviral compounds
#48 | 2013-02-28Inhibitors of flaviviridae viruses
#49 | 2011-07-21Inhibitors of flaviviridae viruses
#50 | 2011-07-21Inhibitors of viruses
#51 | 2011-05-262,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections
#52 | 2011-01-27Inhibitors of flaviviridae viruses
#53 | 2008-10-23Biaryl ether urea compounds
547095 ⎘